People | December 06, 2024
AstraZeneca appoints Iskra Reic as Executive Vice President, International
Iskra has held leadership positions across Central & Eastern Europe, Eurasia, Middle East & Africa at AstraZeneca
Iskra has held leadership positions across Central & Eastern Europe, Eurasia, Middle East & Africa at AstraZeneca
Clarity in regulatory frameworks and pathways help in preventing delays in accessing quality-assured, affordable medicines
Gilead Sciences first launched Lenacapavir under the brand name Sunlenca in the United States and Europe markets in the year 2022
The partnership will provide health plans with an out-of-the-box compliance solution for CMS-9115 and CMS-0057 rules
The acquisition of LumiraDx’s Point of Care technology received all required antitrust and regulatory clearances
Annapurna will lead the company in India ensuring patient access to its highly innovative medicines and vaccines
SELARSDI is approved for both adult and pediatric indications and is the second biosimilar approved under the strategic partnership between Alvotech and Teva
Both organisations enter into a long- term collaboration to expand patient access in India
Collaboration streamlines patient access to oncology clinical trials
Vyleesi is the first and only as-needed treatment approved by the Food and Drug Administration (FDA) for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD)
Subscribe To Our Newsletter & Stay Updated
